News in Brief
Pharmacology - Sep 19
Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar and Mekinist in advanced melanoma
Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar and Mekinist in advanced melanoma
Earth Sciences - Sep 18
Olympic costs are comparable to ’deep disasters’ like pandemics, earthquakes, tsunamis and war
Olympic costs are comparable to ’deep disasters’ like pandemics, earthquakes, tsunamis and war
Campus - Sep 18
Gift establishes two professorships aimed at advancing social equality, inclusion at U-M
Gift establishes two professorships aimed at advancing social equality, inclusion at U-M
Innovation - Sep 18
Eagles project launches crowdfunding campaign in bid to continue work through the pandemic
Eagles project launches crowdfunding campaign in bid to continue work through the pandemic
Health - Sep 17
UC San Diego Scientists to Explore New Frontiers in Parkinson’s Disease Research with $7.2M Grant
UC San Diego Scientists to Explore New Frontiers in Parkinson’s Disease Research with $7.2M Grant
science wire
« BACK
Health - 26.08.2020
Health - Pharmacology - 26.08.2020 
Sex differences in COVID-19 immune responses affect patient outcomes
Yale researchers have identified significant differences in how the immune systems of women and men respond to the virus that causes COVID-19.
Health - 26.08.2020
Health - Pharmacology - 26.08.2020
Materials Science - Health - 26.08.2020
Health - 26.08.2020
Health - 26.08.2020
Pharmacology - Health - 26.08.2020
Pharmacology - Health - 26.08.2020
Pharmacology - Health - 26.08.2020 
’The love hormone’ - a new treatment for addiction?
Even people desperate to end their substance abuse often can't. But thinking differently about how the brain is affected by addiction means the answer could be, ironically, in a pill.
Pharmacology - Health - 25.08.2020
Health - 25.08.2020
Health - Pharmacology - 25.08.2020
Health - Pharmacology - 25.08.2020
Health - Career - 25.08.2020
Health - 25.08.2020
Health - Life Sciences - 24.08.2020 
Breast cancer: New way for tumor cells to escape self-destruction
In the body, so-called programmed cell death prevents cells with irreparable damage from surviving and turning into cancer cells. In the "EMBO Journal", researchers at the University of Basel's Biozentrum, report how a certain protein variant thwarts the self-destruction and thus promotes the growth of breast cancer cells.
Health - Computer Science - 24.08.2020
Environment - Health - 24.08.2020
Health - Pedagogy - 24.08.2020
Pharmacology - Health - 24.08.2020
Social Sciences - Health - 24.08.2020
Health - Social Sciences - 24.08.2020
Health - Life Sciences - 24.08.2020
Physics - Health - 24.08.2020
Health - 24.08.2020
Health - 24.08.2020
Health - Pharmacology - 24.08.2020
Pharmacology - Health - 22.08.2020
Health - Law - 21.08.2020
Social Sciences - Health - 21.08.2020
Pharmacology - Health - 20.08.2020
Health - Social Sciences - 20.08.2020
Health - Career - 20.08.2020
Health - Pharmacology - 20.08.2020
Health - 20.08.2020
Health - Environment - 20.08.2020
Health - 20.08.2020
Health - Pharmacology - 20.08.2020
Health - 20.08.2020 
Families are restricted from visiting hospitalized loved ones. What does this mean for at-home care?
While necessary to help prevent the spread of COVID-19, an unintended side effect of barring hospital visitors during the pandemic has been families' loss of learning how to care for ill or injured loved ones at their bedside.
Health - 20.08.2020
Health - Social Sciences - 20.08.2020
Health - Career - 19.08.2020
Health - Life Sciences - 19.08.2020 
Prevention of heart disease can start before birth
Mitochondrial therapy in complicated pregnancies lowers the chance of cardiovascular problems in the offspring. It completely changes our way of thinking about heart disease Dino Giussani Babies that experience low oxygen levels in the womb due to pregnancy complications often go on to develop heart disease in adulthood.
Health - Pharmacology - 19.08.2020
Health - Career - 19.08.2020
Health - 19.08.2020
Health - Mechanical Engineering - 19.08.2020 
Safe busing during COVID-19: The science behind U-M’s changes
In an effort to design a safe campus bus system for the fall semester in light of COVID-19, University of Michigan researchers simulated how aerosol particles exhaled from passengers sitting in any seat would travel through the vehicle under different conditions.
Health - 19.08.2020
Health - Event - 19.08.2020
Health
Results 151 - 200 of 22709.
Yale researchers have identified significant differences in how the immune systems of women and men respond to the virus that causes COVID-19.
Breakthrough in eliminating dengue, other mosquito-borne diseases
Aedes aegypti mosquitoes carry many viral diseases, including dengue, Zika and yellow fever. They're now invading the U.S. A 27-month trial in Indonesia of a unique method of mosquito control shows that the strategy can reduce the incidence of dengue - a mosquito-borne viral disease of the tropics that threatens nearly half the world's population - by 77%.
Aedes aegypti mosquitoes carry many viral diseases, including dengue, Zika and yellow fever. They're now invading the U.S. A 27-month trial in Indonesia of a unique method of mosquito control shows that the strategy can reduce the incidence of dengue - a mosquito-borne viral disease of the tropics that threatens nearly half the world's population - by 77%.
UW experts design masks for campus from scratch
Students and staff returning to the University of Wisconsin-Madison can protect each other from COVID-19 with masks designed by the university's experts in textiles, filtration and infectious disease, and made by one of Wisconsin's oldest companies.
Students and staff returning to the University of Wisconsin-Madison can protect each other from COVID-19 with masks designed by the university's experts in textiles, filtration and infectious disease, and made by one of Wisconsin's oldest companies.
Molding Masks Against Coronavirus
Winning CMU design awaits FDA approval Amid the current coronavirus pandemic there is a shortage of protective masks, especially the very protective N95 mask.
Winning CMU design awaits FDA approval Amid the current coronavirus pandemic there is a shortage of protective masks, especially the very protective N95 mask.
Novartis investigational novel STAMP inhibitor asciminib (ABL001) meets primary endpoint of Phase III chronic myeloid leukemia study
At primary analysis, ASCEMBL met its primary endpoint of significant superiority in major molecular response rate at 24 weeks for asciminib (ABL001) vs.
At primary analysis, ASCEMBL met its primary endpoint of significant superiority in major molecular response rate at 24 weeks for asciminib (ABL001) vs.
UQ vaccine scientists report positive results from pre-clinical testing
Pre-clinical testing of The University of Queensland's COVID-19 vaccine has produced positive indications about its potential effectiveness and manufacturability.
Pre-clinical testing of The University of Queensland's COVID-19 vaccine has produced positive indications about its potential effectiveness and manufacturability.
Even people desperate to end their substance abuse often can't. But thinking differently about how the brain is affected by addiction means the answer could be, ironically, in a pill.
Demographers put COVID-19 death toll into perspective
Funeral director Omar Rodriguez, right, follows his father's casket in May at a cemetery in Queen's, New York.
Funeral director Omar Rodriguez, right, follows his father's casket in May at a cemetery in Queen's, New York.
Better drug treatment for miscarriage as patients struggle to access surgery in Covid-19 pandemic
The trial found that the combined drug treatment worked in 83% of cases, compared to 76% in the placebo group - and crucially, it reduced the need for surgery. A new drug combination is more effective for women having miscarriages without symptoms than current standard NHS treatment, according to an NIHR funded study from Tommy's National Centre for Miscarriage Research published today in The Lancet.
The trial found that the combined drug treatment worked in 83% of cases, compared to 76% in the placebo group - and crucially, it reduced the need for surgery. A new drug combination is more effective for women having miscarriages without symptoms than current standard NHS treatment, according to an NIHR funded study from Tommy's National Centre for Miscarriage Research published today in The Lancet.
U-M spinout Asalyxa Bio developing inflammatory treatment platform, aiding COVID-19 patients
Asalyxa Bio, a startup with neutrophil targeting drug-delivery technology invented at University of Michigan that aims to treat a wide range of inflammatory diseases, has secured seed funding to advance toward the first in-human trials next year.
Asalyxa Bio, a startup with neutrophil targeting drug-delivery technology invented at University of Michigan that aims to treat a wide range of inflammatory diseases, has secured seed funding to advance toward the first in-human trials next year.
Housing-First strategy proves cost effective especially for the most-vulnerable homeless group
Canadians spend big money dealing with the consequences of homelessness, but the money spent could be far more effective.
Canadians spend big money dealing with the consequences of homelessness, but the money spent could be far more effective.
In the body, so-called programmed cell death prevents cells with irreparable damage from surviving and turning into cancer cells. In the "EMBO Journal", researchers at the University of Basel's Biozentrum, report how a certain protein variant thwarts the self-destruction and thus promotes the growth of breast cancer cells.
Students use AI for a Better Prediction COVID-19 Model
At a Glance Leadership President Provost Board of Trustees Legacy History & Milestones Historic Awards & Honors Caltech Archives Interactive History Map News Publications This is Caltech Calte
At a Glance Leadership President Provost Board of Trustees Legacy History & Milestones Historic Awards & Honors Caltech Archives Interactive History Map News Publications This is Caltech Calte
COVID-19 pandemic should be a wake-up call for water security
Urgent action on water security is essential to better prepare societies for future global health crises, say experts at the University of Birminghamin the UK and Northwestern University in the US.
Urgent action on water security is essential to better prepare societies for future global health crises, say experts at the University of Birminghamin the UK and Northwestern University in the US.
Mail delays may affect medication supply for nearly 1 in 4 Americans over 50
Data from the National Poll on Healthy Aging show reliance on delivery of medications, often because of insurance requirements The timeliness of mail delivery may affect access to medication for many
Data from the National Poll on Healthy Aging show reliance on delivery of medications, often because of insurance requirements The timeliness of mail delivery may affect access to medication for many
Excessive Fructose Consumption May Cause a Leaky Gut, Leading to Fatty Liver Disease
In mouse studies, UC San Diego researchers suggest that finding ways to prevent disruption of the intestinal barrier by high fructose corn syrup could avoid subsequent non-alcoholic fatty liver disease High fructose corn syrup is a ubiquitous food sweetener and linked to numerous diseases and public health issues.
In mouse studies, UC San Diego researchers suggest that finding ways to prevent disruption of the intestinal barrier by high fructose corn syrup could avoid subsequent non-alcoholic fatty liver disease High fructose corn syrup is a ubiquitous food sweetener and linked to numerous diseases and public health issues.
Studies neutralizing monoclonal antibodies as possible treatment for COVID-19
The National Institutes of Health (NIH) and Operation Warp Speed have chosen a University of Minnesota School of Public Health research team to begin a global clinical trial of synthetic versions of natural human antibodies - called neutralizing monoclonal antibodies - as a treatment for COVID-19.
The National Institutes of Health (NIH) and Operation Warp Speed have chosen a University of Minnesota School of Public Health research team to begin a global clinical trial of synthetic versions of natural human antibodies - called neutralizing monoclonal antibodies - as a treatment for COVID-19.
Novartis provides update on Phase III study evaluating investigational spartalizumab (PDR001) in combination with Tafinlar + Mekinist in advanced melanoma
Phase III COMBI-i trial did not meet primary endpoint for patients with advanced BRAF V600-mutated melanoma Tafinlar + Mekinist remains an effective treatment option based on previously reported larg
Phase III COMBI-i trial did not meet primary endpoint for patients with advanced BRAF V600-mutated melanoma Tafinlar + Mekinist remains an effective treatment option based on previously reported larg
How a Law School clinic fought for affordable energy amid COVID-19
When the coronavirus pandemic began this past spring, University of Chicago Law School scholars and students had already spent months battling Detroit's electricity provider over a proposed rate increase.
When the coronavirus pandemic began this past spring, University of Chicago Law School scholars and students had already spent months battling Detroit's electricity provider over a proposed rate increase.
FDA approves Novartis Kesimpta (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis
Kesimpta delivers powerful efficacy with a favorable safety profile and can be self-administered at home, addressing significant unmet needs for people living with relapsing forms of multiple scleros
Kesimpta delivers powerful efficacy with a favorable safety profile and can be self-administered at home, addressing significant unmet needs for people living with relapsing forms of multiple scleros
UC San Diego Asymptomatic Employee COVID-19 Testing Available Now
All faculty, staff and student employees are now eligible to schedule a no-cost asymptomatic COVID-19 test.
All faculty, staff and student employees are now eligible to schedule a no-cost asymptomatic COVID-19 test.
One Life, Two Viruses: HIV and SARS-CoV-2
UC San Diego infectious disease researchers are striving to understand the complexities of living with HIV and acquiring COVID-19 E very day, she donned a mask and was vigilant about washing her hand
UC San Diego infectious disease researchers are striving to understand the complexities of living with HIV and acquiring COVID-19 E very day, she donned a mask and was vigilant about washing her hand
Spotlight on... Jasmine Ho
This week we meet Jasmine Ho, Clinical Research Training Fellow at the Ear Institute. Here, Jasmine chats to us about founding the PPE charity MedSupplyDrive UK, which has directed over 250,000 items of PPE to more than 500 health and social care establishments to date.
This week we meet Jasmine Ho, Clinical Research Training Fellow at the Ear Institute. Here, Jasmine chats to us about founding the PPE charity MedSupplyDrive UK, which has directed over 250,000 items of PPE to more than 500 health and social care establishments to date.
Opinion: Making COVID-19 research open to all
UCL's COVID-19 Research platform reached a landmark moment this August as it recorded its 500th entry.
UCL's COVID-19 Research platform reached a landmark moment this August as it recorded its 500th entry.
Analysis: How UCL clinicians invented a new way of treating breast cancer
As a large trial confirms the effectiveness of single-dose radiotherapy in treating breast cancer, Principle Investigator, Professor Jayant Vaidya (UCL Surgery & Interventional Science), describes how he and colleagues developed a new therapy which challenged convention.
As a large trial confirms the effectiveness of single-dose radiotherapy in treating breast cancer, Principle Investigator, Professor Jayant Vaidya (UCL Surgery & Interventional Science), describes how he and colleagues developed a new therapy which challenged convention.
While necessary to help prevent the spread of COVID-19, an unintended side effect of barring hospital visitors during the pandemic has been families' loss of learning how to care for ill or injured loved ones at their bedside.
Tackling COVID-19: Professor Daniela De Angelis
Since January this year, Daniela De Angelis and her team have been informing the UK Government's response to the COVID-19 pandemic.
Since January this year, Daniela De Angelis and her team have been informing the UK Government's response to the COVID-19 pandemic.
Preparing for wildfire smoke during the coronavirus pandemic
University Health Services Medical Director Dr. Anna Harte, Executive Director of Environment, Health and Safety Patrick Goff and Director of the Office of Emergency Management Alicia Johnson
University Health Services Medical Director Dr. Anna Harte, Executive Director of Environment, Health and Safety Patrick Goff and Director of the Office of Emergency Management Alicia Johnson
Mitochondrial therapy in complicated pregnancies lowers the chance of cardiovascular problems in the offspring. It completely changes our way of thinking about heart disease Dino Giussani Babies that experience low oxygen levels in the womb due to pregnancy complications often go on to develop heart disease in adulthood.
Researchers extend recruitment to COVID-19 vaccine trial
Researchers at University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), North Bristol NHS Trust (NBT) and the University of Bristol have begun a new round of recruitment to a clinical trial of a vaccine pioneered in the UK which could protect against COVID-19.
Researchers at University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), North Bristol NHS Trust (NBT) and the University of Bristol have begun a new round of recruitment to a clinical trial of a vaccine pioneered in the UK which could protect against COVID-19.
How the COVID-19 pandemic has disrupted demand in the gig economy
While the use of ride-hailing transportation services has plummeted since the coronavirus outbreak, many Americans continue to use grocery and restaurant delivery services, despite safety concerns for themselves and workers.
While the use of ride-hailing transportation services has plummeted since the coronavirus outbreak, many Americans continue to use grocery and restaurant delivery services, despite safety concerns for themselves and workers.
Balancing act: Falls are often early signal of underlying health problems in older adults
In older adults, the risk of a fall injury rises substantially in the month before a hospitalization and remains elevated after discharge, a University of Michigan study found.
In older adults, the risk of a fall injury rises substantially in the month before a hospitalization and remains elevated after discharge, a University of Michigan study found.
In an effort to design a safe campus bus system for the fall semester in light of COVID-19, University of Michigan researchers simulated how aerosol particles exhaled from passengers sitting in any seat would travel through the vehicle under different conditions.
News in Brief
Pharmacology - Sep 19
Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar and Mekinist in advanced melanoma
Novartis reports late-breaking data from Phase III COMBI-i trial of spartalizumab (PDR001) with Tafinlar and Mekinist in advanced melanoma
Earth Sciences - Sep 18
Olympic costs are comparable to ’deep disasters’ like pandemics, earthquakes, tsunamis and war
Olympic costs are comparable to ’deep disasters’ like pandemics, earthquakes, tsunamis and war
Campus - Sep 18
Gift establishes two professorships aimed at advancing social equality, inclusion at U-M
Gift establishes two professorships aimed at advancing social equality, inclusion at U-M
Innovation - Sep 18
Eagles project launches crowdfunding campaign in bid to continue work through the pandemic
Eagles project launches crowdfunding campaign in bid to continue work through the pandemic
Health - Sep 17
UC San Diego Scientists to Explore New Frontiers in Parkinson’s Disease Research with $7.2M Grant
UC San Diego Scientists to Explore New Frontiers in Parkinson’s Disease Research with $7.2M Grant